SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10218450
Source:
http://linkedlifedata.com/resource/pubmed/id/10218450
Search
Subject
(
40
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0029016
,
umls-concept:C0087111
,
umls-concept:C0242957
,
umls-concept:C0302350
,
umls-concept:C0679199
,
umls-concept:C1514475
,
umls-concept:C1521761
,
umls-concept:C1547707
pubmed:issue
2
pubmed:dateCreated
1999-4-29
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8504356
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0748-7983
pubmed:author
pubmed-author:KerinM JMJ
,
pubmed-author:MehiganB JBJ
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
111-2
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10218450-Antibodies, Monoclonal
,
pubmed-meshheading:10218450-Clinical Trials as Topic
,
pubmed-meshheading:10218450-Gene Expression Regulation, Neoplastic
,
pubmed-meshheading:10218450-Humans
,
pubmed-meshheading:10218450-Neoplasms
,
pubmed-meshheading:10218450-Prognosis
,
pubmed-meshheading:10218450-Receptor, erbB-2
,
pubmed-meshheading:10218450-Tumor Markers, Biological
,
pubmed-meshheading:10218450-Up-Regulation
pubmed:year
1999
pubmed:articleTitle
The HER-2/neu story: from oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy.
pubmed:publicationType
Editorial